These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23176400)

  • 41. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
    Louhimo J; Kokkola A; Alfthan H; Stenman UH; Haglund C
    Int J Cancer; 2004 Oct; 111(6):929-33. PubMed ID: 15300805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis.
    Kim YJ; Kim SH; Kim JW; Lee JO; Kim JH; Bang SM; Lee JS; Lee KW
    Eur J Cancer; 2014 Nov; 50(16):2810-21. PubMed ID: 25201165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
    Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
    Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
    Song YX; Huang XZ; Gao P; Sun JX; Chen XW; Yang YC; Zhang C; Liu HP; Wang HC; Wang ZN
    Dis Markers; 2015; 2015():549843. PubMed ID: 26576068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
    Carmignani CP; Hampton R; Sugarbaker CE; Chang D; Sugarbaker PH
    J Surg Oncol; 2004 Sep; 87(4):162-6. PubMed ID: 15334630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
    Tas F; Faruk Aykan N; Aydiner A; Yasasever V; Topuz E
    Am J Clin Oncol; 2001 Apr; 24(2):148-9. PubMed ID: 11319289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.
    Xiao J; He X; Wang Z; Hu J; Sun F; Qi F; Yang S; Xiao Z
    Tumour Biol; 2014 Feb; 35(2):1331-4. PubMed ID: 24234331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study.
    Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Hieda N; Yoshida T; Okuno N; Shimizu Y; Niwa Y; Yamao K
    Pancreatology; 2016; 16(5):859-64. PubMed ID: 27256641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of intercellular adhesion molecule-1 correlate with advanced and metastatic disease and poor prognosis in gastric cancer.
    Polychronidis AC; Tsaroucha AK; Samolis SP; Botaitis SK; Perente SS; Simopoulos CE
    Folia Med (Plovdiv); 2003; 45(1):20-4. PubMed ID: 12943063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients.
    Hung YP; Chen MH; Lin JS; Hsiao CF; Shan YS; Chen YC; Chen LT; Liu TW; Li CP; Chao Y
    J Chin Med Assoc; 2018 Jul; 81(7):593-598. PubMed ID: 29636231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Difference in prognostic value between sialyl Lewis(a) and sialyl Lewis(x) antigen levels in the preoperative serum of gastric cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    J Clin Gastroenterol; 2002 Apr; 34(4):408-15. PubMed ID: 11907351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients.
    Deng K; Yang L; Hu B; Wu H; Zhu H; Tang C
    PLoS One; 2015; 10(4):e0124151. PubMed ID: 25879931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
    Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
    Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients.
    Virgilio E; Proietti A; D'Urso R; Cardelli P; Giarnieri E; Giovagnoli MR; Montagnini M; Villani S; Balducci G; Cavallini M
    Anticancer Res; 2020 Mar; 40(3):1691-1695. PubMed ID: 32132076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.
    Roșu MC; Ardelean A; Moldovan SD; Faur FI; Nesiu A; Totoloci BD
    J Med Life; 2023 Feb; 16(2):186-188. PubMed ID: 36937484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does CA 19-9 Have Prognostic Relevance in Gallbladder Carcinoma (GBC)?
    Agrawal S; Lawrence A; Saxena R
    J Gastrointest Cancer; 2018 Jun; 49(2):144-149. PubMed ID: 28105553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Proposed New Clinical Classification of Metastatic Gastric Cancer: Pyloric and Antral Gastric Cancer.
    Kawagoe T; Ikeda G; Oshiro Y; Kaneko K; Iwakiri K
    J Nippon Med Sch; 2022 May; 89(2):176-183. PubMed ID: 34526459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.